Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC)

By Tanaka F.   Yanagihara K.   Otake Y.   Yamada T.   Shoji T.   Miyahara R.   Inui K.   Wada H.  

European Journal of Cardio-Thoracic Surgery, Vol. 19, Iss. 5, 2001-05 ,pp. : 555-561

Elsevier

Access to resources Recommend Favorite

Time trends and survival after surgery for p-stage IIIa, pN2 non-small cell lung cancer (NSCLC)

By Tanaka F.   Yanagihara K.   Ohtake Y.   Fukuse T.   Hitomi S.   Wada H.  

European Journal of Cardio-Thoracic Surgery, Vol. 12, Iss. 3, 1997-09 ,pp. : 372-379

Elsevier

Access to resources Recommend Favorite

Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer

By Cheng Y.-L.   Lee S.-C.   Harn H.-J.   Chen C.-J.   Chang Y.-C.   Chen J.-C.   Yu C.-P.  

European Journal of Cardio-Thoracic Surgery, Vol. 23, Iss. 2, 2003-02 ,pp. : 221-228

Elsevier

Access to resources Recommend Favorite

Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection

By Yano T.   Fukuyama Y.   Yokoyama H.   Kuninaka S.   Terazaki Y.   Uehara T.   Asoh H.   Ichinose Y.  

European Journal of Cardio-Thoracic Surgery, Vol. 14, Iss. 2, 1998-08 ,pp. : 152-155

Elsevier

Access to resources Recommend Favorite

The prognostic significance of skip mediastinal lymphatic metastasis in resected non-small cell lung cancer

By Gunluoglu Z.   Solak O.   Metin M.   Gurses A.  

European Journal of Cardio-Thoracic Surgery, Vol. 21, Iss. 3, 2002-03 ,pp. : 595-595

Elsevier

Access to resources Recommend Favorite